DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹81 Cr | - | ₹37 Cr | ₹31 Cr | ₹27 Cr |
What is the latest Long Term Provisions ratio of DIVIS LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹81 Cr |
| Mar2025 | - |
| Mar2024 | ₹37 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹27 Cr |
How is Long Term Provisions of DIVIS LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹81 Cr | 0 | |
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹37 Cr | 19.35 | |
| Mar2023 | ₹31 Cr | 16.06 | |
| Mar2022 | ₹27 Cr | - | |
Compare Long Term Provisions of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹297,360.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
| MANKIND PHARMA | ₹109,880.0 Cr | -0.9% | 15.3% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2.7% |
22.2% |
70% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses